Ask the Experts: The impact of artificial intelligence in drug discovery
Artificial intelligence (AI) has become more common, both in our research labs and in our homes, but what are the limitations of AI? We turn to Anne Carpenter (Broad Institute; MA, USA), Wengong Jin (Eric and Wendy Schmidt Center; MA, USA), and Jürgen Bajorath (University of Bonn; Germany) to answer our questions about developing computational techniques for drug discovery, the challenges of doing so, and how this technology might evolve in the future. Questions What is the difference between AI, machine learning and deep learning? In what ways can AI be used to accelerate drug discovery? What have been some...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
